3692 Overzicht aandelen
Hansoh Pharmaceutical Group Company Limited, een investeringsholding, houdt zich bezig met onderzoek, ontwikkeling, productie en verkoop van farmaceutische producten in de Volksrepubliek China.
| Sneeuwvlok Score | |
|---|---|
| Waardering | 3/6 |
| Toekomstige groei | 1/6 |
| Prestaties in het verleden | 5/6 |
| Financiële gezondheid | 5/6 |
| Dividenden | 2/6 |
Hansoh Pharmaceutical Group Company Limited Concurrenten
Prijsgeschiedenis en prestaties
| Historische aandelenkoersen | |
|---|---|
| Huidige aandelenkoers | HK$17.86 |
| 52 Week Hoogtepunt | HK$22.80 |
| 52 Week Laag | HK$11.18 |
| Bèta | 0.61 |
| 11 maand verandering | -17.31% |
| 3 maanden verandering | -3.04% |
| 1 Jaar Verandering | 20.19% |
| 33 jaar verandering | 5.18% |
| 5 jaar verandering | -25.58% |
| Verandering sinds IPO | -8.41% |
Recent nieuws en updates
Recent updates
Is Now The Time To Put Hansoh Pharmaceutical Group (HKG:3692) On Your Watchlist?
Nov 04
Estimating The Fair Value Of Hansoh Pharmaceutical Group Company Limited (HKG:3692)
Aug 28Pinning Down Hansoh Pharmaceutical Group Company Limited's (HKG:3692) P/E Is Difficult Right Now
Aug 07If EPS Growth Is Important To You, Hansoh Pharmaceutical Group (HKG:3692) Presents An Opportunity
Jul 16Hansoh Pharmaceutical Group (HKG:3692) Could Easily Take On More Debt
Jun 24Hansoh Pharmaceutical Group Company Limited's (HKG:3692) CEO Will Probably Find It Hard To See A Huge Raise This Year
Jun 06Estimating The Intrinsic Value Of Hansoh Pharmaceutical Group Company Limited (HKG:3692)
May 23Hansoh Pharmaceutical Group Company Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
May 01Do Hansoh Pharmaceutical Group's (HKG:3692) Earnings Warrant Your Attention?
Mar 28There's Reason For Concern Over Hansoh Pharmaceutical Group Company Limited's (HKG:3692) Massive 28% Price Jump
Mar 04An Intrinsic Calculation For Hansoh Pharmaceutical Group Company Limited (HKG:3692) Suggests It's 28% Undervalued
Feb 16Hansoh Pharmaceutical Group (HKG:3692) Seems To Use Debt Quite Sensibly
Dec 08Hansoh Pharmaceutical Group Company Limited (HKG:3692) Shares Could Be 25% Below Their Intrinsic Value Estimate
Oct 12Hansoh Pharmaceutical Group's (HKG:3692) Upcoming Dividend Will Be Larger Than Last Year's
Sep 14These 4 Measures Indicate That Hansoh Pharmaceutical Group (HKG:3692) Is Using Debt Reasonably Well
Sep 09Calculating The Intrinsic Value Of Hansoh Pharmaceutical Group Company Limited (HKG:3692)
Jul 10These 4 Measures Indicate That Hansoh Pharmaceutical Group (HKG:3692) Is Using Debt Reasonably Well
Jun 11Calculating The Fair Value Of Hansoh Pharmaceutical Group Company Limited (HKG:3692)
Jan 23Hansoh Pharmaceutical Group (HKG:3692) Has A Rock Solid Balance Sheet
Dec 01Hansoh Pharmaceutical Group Company Limited's (HKG:3692) Intrinsic Value Is Potentially 65% Above Its Share Price
Oct 19Hansoh Pharmaceutical Group (HKG:3692) Could Easily Take On More Debt
Aug 28An Intrinsic Calculation For Hansoh Pharmaceutical Group Company Limited (HKG:3692) Suggests It's 44% Undervalued
Jun 09Hansoh Pharmaceutical Group Company Limited's (HKG:3692) Popularity With Investors Is Under Threat From Overpricing
May 19Is Hansoh Pharmaceutical Group (HKG:3692) A Risky Investment?
Apr 22An Intrinsic Calculation For Hansoh Pharmaceutical Group Company Limited (HKG:3692) Suggests It's 45% Undervalued
Feb 06Rendement voor aandeelhouders
| 3692 | HK Pharmaceuticals | HK Markt | |
|---|---|---|---|
| 7D | -13.5% | -7.2% | -1.0% |
| 1Y | 20.2% | -2.9% | 15.0% |
Rendement versus industrie: 3692 exceeded the Hong Kong Pharmaceuticals industry which returned -2.9% over the past year.
Rendement versus markt: 3692 exceeded the Hong Kong Market which returned 15% over the past year.
Prijsvolatiliteit
| 3692 volatility | |
|---|---|
| 3692 Average Weekly Movement | 8.3% |
| Pharmaceuticals Industry Average Movement | 6.9% |
| Market Average Movement | 9.0% |
| 10% most volatile stocks in HK Market | 19.0% |
| 10% least volatile stocks in HK Market | 4.3% |
Stabiele aandelenkoers: 3692 has not had significant price volatility in the past 3 months compared to the Hong Kong market.
Volatiliteit in de loop van de tijd: 3692's weekly volatility (8%) has been stable over the past year.
Over het bedrijf
| Opgericht | Werknemers | CEO | Website |
|---|---|---|---|
| 1995 | 9,099 | Huijuan Zhong | www.hspharm.com |
Hansoh Pharmaceutical Group Company Limited, een investeringsmaatschappij, houdt zich bezig met onderzoek, ontwikkeling, productie en verkoop van farmaceutische producten in de Volksrepubliek China. Het bedrijf levert producten voor therapeutische gebieden, waaronder tumorbestrijding, infectiebestrijding, ziekten van het centrale zenuwstelsel, oncologie, stofwisselingsziekten en auto-immuunziekten, enz. De belangrijkste producten zijn Ameile, Hansoh Xinfu, Pulaile, Zefei, Xintai, Xinmei, Gainuo, Hengmu, Mailingda, Hengsen, XINYUE, Saint Luolai, Fulaimei, Pulaitan, Tanneng, Ameining, Oulanning, Ruibote, Fulaidi, Fulairui en Puruian tabletten.
Hansoh Pharmaceutical Group Company Limited Samenvatting
| 3692 fundamentele statistieken | |
|---|---|
| Marktkapitalisatie | HK$105.87b |
| Inkomsten(TTM) | HK$5.17b |
| Inkomsten(TTM) | HK$13.26b |
20.5x
Koers/Winstverhouding8.0x
P/S-verhoudingIs 3692 overgewaardeerd?
Zie Reële waarde en waarderingsanalyseInkomsten en omzet
| 3692 resultatenrekening (TTM) | |
|---|---|
| Inkomsten | CN¥12.10b |
| Kosten van inkomsten | CN¥1.09b |
| Brutowinst | CN¥11.01b |
| Overige uitgaven | CN¥6.30b |
| Inkomsten | CN¥4.71b |
Laatst gerapporteerde inkomsten
Jun 30, 2024
Volgende inkomensdatum
n.v.t.
| Winst per aandeel (EPS) | 0.79 |
| Brutomarge | 91.01% |
| Nettowinstmarge | 38.97% |
| Schuld/Eigen Vermogen Verhouding | 0.1% |
Hoe presteerde 3692 op de lange termijn?
Bekijk historische prestaties en vergelijking